Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients

被引:7
|
作者
Berruti, Alfredo [1 ]
Tucci, Marcello
Mosca, Alessandra
Vana, Federica
Ardine, Mara
Dogliotti, Luigi
Angeli, Alberto
Bertoldo, Francesco
机构
[1] Univ Turin, Oncol Med Azienda Osped San Luigi, Dipartimento Sci Clin & Biol, Orbassano, Italy
[2] Azienda Sanitaria Locale 8, Chiezi, Italy
[3] Univ Verona, Policlin GB Rossi, Dipartimento Sci Biomed & Chirurg, Sez Med D, I-37100 Verona, Italy
关键词
D O I
10.1200/JCO.2006.08.7080
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1455 / 1456
页数:3
相关论文
共 50 条
  • [1] Impact of adjuvant aromatase inhibitors on bone mineral density in breast cancer patients
    Lai, C. N.
    Correa, P. D.
    Alhasso, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] EFFECT OF AROMATASE INHIBITORS ON BONE MINERAL DENSITY IN PATIENTS WITH BREAST CANCER
    Khachidze, N.
    Giorgadze, E.
    Tsagareli, M.
    Dolidze, N.
    Sharikadze, N.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S237 - S238
  • [3] Changes in bone mineral density with adjuvant aromatase inhibitor treatment and breast cancer recurrence.
    Martin, Hilary
    Redfern, Andrew D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Effects of Aromatase inhibitors on bone mineral density and trabecular bone score in patients with breast cancer
    Dabbagh, V.
    Shandiz, F. Homaee
    Kermani, A. Taghizadeh
    Javan, F. Nesari
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S465 - S465
  • [5] EFFECT OF AROMATASE INHIBITORS ON BONE MINERAL DENSITY AND TRABECULAR BONE MICROARCHITECTURE IN PATIENTS WITH BREAST CANCER
    Tsagareli, M.
    Giorgadze, E.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S189 - S189
  • [6] Bone mineral density in women with breast cancer and the impact of aromatase inhibitors
    Saleh, B.
    Gronland, N.
    Singer, J.
    Bradpiece, H.
    Patel, A.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : 384 - 385
  • [7] Fracture threshold in breast cancer patients treated with adjuvant aromatase inhibitors
    Bertoldo, F.
    Dalle Carbonare, L.
    Zenari, S.
    Pancheri, S.
    Zanatta, M.
    Giovanazzi, B.
    Valenti, M. T.
    Lo Cascio, V.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S161 - S161
  • [8] Bone mineral density screening and monitoring in early breast cancer patients treated with aromatase inhibitors
    Gilani, S.
    Ikram, N.
    ANNALS OF ONCOLOGY, 2022, 33 : S227 - S227
  • [9] Bone Mineral Density Testing Disparities Among Patients With Breast Cancer Prescribed Aromatase Inhibitors
    Charlson, John
    Smith, Elizabeth C.
    Smallwood, Alicia J.
    Laud, Purushottam W.
    Neuner, Joan M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (07): : 875 - 880
  • [10] Bone mineral density change on aromatase inhibitors as a predictor of breast cancer recurrence
    Martin, Hilary L.
    Davidson, John A.
    Yap, Francis
    Chung, Kim
    Khattak, Muhammad A.
    Redfern, Andrew D.
    CANCER RESEARCH, 2015, 75